References
Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P (2018) Drug-induced aseptic meningitis: a mini-review. Fundam Clin Pharmacol 32:252–260. https://doi.org/10.1111/fcp.12349
Bihan K, Weiss N, Théophile H, Funck-Brentano C, Lebrun-Vignes B (2019) Drug-induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis. Br J Clin Pharmacol 85(11):2540–2546. https://doi.org/10.1111/bcp.14073
Guo Y, Tian X, Wang X, Xiao Z (2018) Adverse effects of immunoglobulin therapy. Front Immunol 9:1299. https://doi.org/10.3389/fimmu.2018.01299
Berg R, Fuellenhals E (2016) Aseptic meningitis following therapy with immune globulins: a combination of product features and patient characteristics? Transfusion 56(12):3021–3028. https://doi.org/10.1111/trf.13886
Alrohimi A, Jassal R (2018) Headache in Guillain–Barré syndrome: diagnostic and management implications. Can J Neurol Sci 45(2):240–242. https://doi.org/10.1017/cjn.2017.247
Author information
Authors and Affiliations
Contributions
The first draft of the manuscript was written by SMS and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest related to this submission.
Informed consent
Consent of the patient was obtained prior to submission.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Maldonado Slootjes, S., Guilmot, A., Dubuisson, N. et al. Intravenous immunoglobulin-induced aseptic meningitis in a patient with Miller Fisher syndrome. Acta Neurol Belg 120, 1015–1016 (2020). https://doi.org/10.1007/s13760-020-01389-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-020-01389-0